EDGAR Filing Documents for 0001047469-09-009091

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001047469-09-009091

Filing Date

2009-10-21

Accepted

2009-10-21 16:56:17

Documents

Period of Report

2009-09-30

Items

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K/A	a2194973z8-ka.htm	8-K/A	22215
2	EXHIBIT 23.1	a2194973zex-23_1.htm	EX-23.1	2678
3	EXHIBIT 99.1	a2194973zex-99_1.htm	EX-99.1	623108
4	EXHIBIT 99.2	a2194973zex-99_2.htm	EX-99.2	185849
5	EXHIBIT 99.3	a2194973zex-99_3.htm	EX-99.3	268321
6	EXHIBIT 99.4	a2194973zex-99_4.htm	EX-99.4	190877
	Complete submission text file	0001047469-09-009091.txt		1294766

Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725

Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771

Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)